These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11994264)

  • 1. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.
    Eckel RH; Wassef M; Chait A; Sobel B; Barrett E; King G; Lopes-Virella M; Reusch J; Ruderman N; Steiner G; Vlassara H
    Circulation; 2002 May; 105(18):e138-43. PubMed ID: 11994264
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology.
    Howard BV; Rodriguez BL; Bennett PH; Harris MI; Hamman R; Kuller LH; Pearson TA; Wylie-Rosett J
    Circulation; 2002 May; 105(18):e132-7. PubMed ID: 11994263
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy.
    Laight DW; Carrier MJ; Anggård EE
    Diabetes Metab Res Rev; 1999; 15(4):274-82. PubMed ID: 10495476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.
    Dandona P; Aljada A; Chaudhuri A; Bandyopadhyay A
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2422-9. PubMed ID: 12788837
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
    Plutzky J; Viberti G; Haffner S
    J Diabetes Complications; 2002; 16(6):401-15. PubMed ID: 12477625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
    Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
    J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelium, inflammation, and diabetes.
    Dandona P
    Curr Diab Rep; 2002 Aug; 2(4):311-5. PubMed ID: 12643190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus?
    Golden SH; Chong R
    Curr Diab Rep; 2004 Feb; 4(1):26-30. PubMed ID: 14764276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and atherosclerosis--a lipoprotein perspective.
    Steiner G
    Diabet Med; 1997 Aug; 14 Suppl 3():S38-44. PubMed ID: 9272612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors.
    Grundy SM; Garber A; Goldberg R; Havas S; Holman R; Lamendola C; Howard WJ; Savage P; Sowers J; Vega GL
    Circulation; 2002 May; 105(18):e153-8. PubMed ID: 11994266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Control of atherosclerosis in diabetes mellitus].
    Quiroz Martínez A
    Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular disease prevention in patients with diabetes.
    Gavin J; Kagan S
    Diabetes Obes Metab; 2000 Nov; 2 Suppl 2():S25-36. PubMed ID: 11210242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
    Lewis GF; Steiner G
    Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
    [No Abstract]   [Full Text] [Related]  

  • 15. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
    Mazzone T
    J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association.
    Grundy SM; Howard B; Smith S; Eckel R; Redberg R; Bonow RO
    Circulation; 2002 May; 105(18):2231-9. PubMed ID: 11994261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention and treatment for development and progression of diabetic macroangiopathy with pioglitazone and metformin].
    Tamura H; Mokuno H; Daita H
    Nihon Rinsho; 2006 Nov; 64(11):2119-25. PubMed ID: 17087306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of vascular disease in diabetes: effects of gliclazide.
    Colwell JA
    Am J Med; 1991 Jun; 90(6A):50S-54S. PubMed ID: 1872305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and risk factors of atherosclerotic disease, with special emphasis on diabetes mellitus.
    Wilkens HJ; Back N
    Circ Shock; 1978; 5(2):125-43. PubMed ID: 352570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity and vascular disease in maturity-onset diabetics.
    Stocks AE; Martin FI
    Br Med J; 1969 Nov; 4(5680):397-9. PubMed ID: 5354810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.